Peculiarities of acute gouty arthritis treatment in patients with concomitant pathology. Part 1: main limitations and adverse effects of medicamentous therapy
- Autores: Lyalina V.1, Skripnichenko E.1,2, Borisovskaya S.1,2, Obyedkov R.1, Nikitin I.1
-
Afiliações:
- N.I. Porogov Russian National Research Medical University of the Ministry of Healthcare of Russia
- V.M. Buyanov City Clinical Hospital of the Department of Healthcare of Moscow
- Edição: Volume 9, Nº 1 (2023)
- Páginas: 100-106
- Seção: LECTURES & REPORTS
- URL: https://journals.rcsi.science/2412-4036/article/view/258801
- DOI: https://doi.org/10.18565/therapy.2023.1.100–107
- ID: 258801
Citar
Resumo
Acute gouty arthritis is characterized by expressed inflammatory symptoms and severe pain syndrome, requiring immediate medical relief. Article discusses the general points of anti-inflammatory medicines (non-steroidal anti-inflammatory drugs, glucocorticosteroids, colchicine) use acute gouty arthritis treatment against the background of associated risks in comorbid patients.
Texto integral
##article.viewOnOriginalSite##Sobre autores
Vera Lyalina
N.I. Porogov Russian National Research Medical University of the Ministry of Healthcare of Russia
Autor responsável pela correspondência
Email: vera_lyalina@mail.ru
ORCID ID: 0000-0002-4262-4060
PhD in Medical Sciences, associate professor of the Department of hospital therapy named after academician G.I. Storozhakov of the Faculty of general medicine
Rússia, 117997, Moscow, 1 Ostrovityanova Str.Elina Skripnichenko
N.I. Porogov Russian National Research Medical University of the Ministry of Healthcare of Russia; V.M. Buyanov City Clinical Hospital of the Department of Healthcare of Moscow
Email: elkaskrip@gmail.com
ORCID ID: 0000-0001-6321-8419
postgraduate student of the Department of hospital therapy named after academician G.I. Storozhakov of the Faculty of general medicine
Rússia, 117997, Moscow, 1 Ostrovityanova Str.; MoscowSvetlana Borisovskaya
N.I. Porogov Russian National Research Medical University of the Ministry of Healthcare of Russia; V.M. Buyanov City Clinical Hospital of the Department of Healthcare of Moscow
Email: svabor@inbox.ru
ORCID ID: 0000-0002-9365-1472
PhD in Medical Sciences, associate professor of the Department of hospital therapy named after academician G.I. Storozhakov of the Faculty of general medicine
Rússia, 117997, Moscow, 1 Ostrovityanova Str.; MoscowRuslan Obyedkov
N.I. Porogov Russian National Research Medical University of the Ministry of Healthcare of Russia
Email: rn.obedkov98@gmail.com
ORCID ID: 0000-0002-8689-6623
student of the Department of hospital therapy named after academician G.I. Storozhakov of the Faculty of general medicine
Rússia, 117997, Moscow, 1 Ostrovityanova Str.Igor Nikitin
N.I. Porogov Russian National Research Medical University of the Ministry of Healthcare of Russia
Email: igor.nikitin.64@mail.ru
ORCID ID: 0000-0003-1699-0881
MD, professor, head of the Department of hospital therapy No. 2 of the Faculty of general medicine, director
Rússia, 117997, Moscow, 1 Ostrovityanova Str.Bibliografia
- Насонова В.А., Барскова В.Г. Ранние диагностика и лечение подагры – научно обоснованное требование улучшения трудового и жизненного прогноза больных. Научно-практическая ревматология. 2004; 42(1): 5–7. [Nasonova V. A., Barskova V. G. Early diagnosis and treatment of gout is a scientifically based requirement for improving the work and life prognosis of patients. Nauchno-prakticheskaya revmatologiya = Scientific and Practical Rheumatology. 2004; 42(1): 5–7. EDN: QCWYZP.
- Дженсон Р. У. Подагра. В кн.: Секреты ревматологии. Под. ред. Стерлинга Дж. Уэста (пер. с англ. под ред. О.М. Лесняк). М.: ГЭОТАР-Медиа. 2018; с. 359–367. [Jenson R.W. Gout. In: Rheumatology secrets. Ed. by Sterling J. West (translation from English edited by O.M. Lesnyak). Moscow: GEOTAR-Media. 2018; pp. 359–367 (In Russ.)]. ISBN: 978-5-9704-4508-2.
- MSD Manual. Keller S.F. Gout. 2022. URL: https://www.msdmanuals.com/professional/musculoskeletal-and-connective-tissue-disorders/crystal-induced-arthritides/gout (date of access – 01.02.2023).
- Medscape. Rothschild B.M. Gout and pseudogout. 2020 (Updated: Jan 11, 2023). URL: https://emedicine.medscape.com/article/329958-overview (date of access – 01.02.2023).
- Клинические рекомендации. Подагра. Ассоциация ревматологов России. 2018. ID: 251. Доступ: https://legalacts.ru/doc/klinicheskie-rekomendatsii-podagra-utv-minzdravom-rossii/ (дата обращения – 01.01.2023). [Clinical guidelines. Gout. Association of Rheumatologists of Russia. 2018. ID: 251. URL: https://legalacts.ru/doc/klinicheskie-rekomendatsii-podagra-utv-minzdravom-rossii/ (date of access – 01.01.2023).
- Pillinger M.H., Mandell B.F. Therapeutic approaches in the treatment of gout. Semin Arthritis Rheum. 2020; 50(3S): S24–S30. https://dx.doi.org/10.1016/j.semarthrit.2020.04.010.
- Gow P. Treating gout in patients with comorbidities. Int J Clin Rheumtol. 2011; 6(6): 625–33. https://dx.doi.org/10.2217/ijr.11.63.
- UpToDate. Gaffo A.L. Treatment of gout flares. 2022. URL: https://www.uptodate.com/contents/treatment-of-gout-flares (date of access – 01.01.2023).
- Елисеев М.С., Насонов Е.Л. Применение канакинумаба при подагре. Научно-практическая ревматология. 2018; 56(S4): 41–48. [Eliseev MS, Nasonov EL. Therapy with canakinumab for gout. Nauchno-prakticheskaya revmatologiya = Scientific and Practical Rheumatology. 2018; 56(S4): 41–48 (In Russ.)]. https://dx.doi.org/10.14412/1995-4484-2018-41-48.
- Каратеев А.Е., Насонов Е.Л., Ивашкин В.Т. с соавт. Рациональное использование нестероидных противовоспалительных препаратов. Клинические рекомендации. Научно-практическая ревматология. 2018; 56(S1): 1–29. [Karateev A. E., Nasonov E. L., Ivashkin V. T. et al. Rational use of non-steroidal anti-inflammatory drugs. Clinical guidelines. Nauchno-prakticheskaya revmatologiya = Scientific and Practical Rheumatology. 2018; 56(S1): 1–29 (In Russ.)]. https://dx.doi.org/10.14412/1995-4484-2018-1-29. EDN: PCPKRP.
- Yu T.F., Gutman A.B. Study of the paradoxical effects of salicylate in low, intermediate and high dosage on the renal mechanisms for excretion of urate in man. J Clin Invest. 1959; 38(8): 1298–315. https://dx.doi.org/10.1172/JCI103905.
- Фингер Д.Р. Гипоурикемические средства и колхицин. В кн.: Секреты ревматологии. Под. ред. Стерлинга Дж. Уэста (пер. с англ. под ред. О.М. Лесняк). М.: ГЭОТАР-Медиа. 2018; с. 683–690. [Finger D.R. Hypouricemic drugs and colchicine. In: Rheumatology secrets. Ed. by Sterling J. West (translation from English edited by O.M. Lesnyak). Moscow: GEOTAR-Media. 2018; pp. 683–690 (In Russ.)]. ISBN: 978-5-9704-4508-2.
- Terkeltaub R.A., Furst D.E., DiGiacinto J.L. et al. Novel evidence-based colchicine dose-reduction algorithm to predict and prevent colchicine toxicity in the presence of cytochrome P450 3A4/P-glycoprotein inhibitors. Arthritis Rheum. 2011; 63(8): 2226–37. https://dx.doi.org/10.1002/art.30389.
- FDA. Drug development and drug interactions. Table of substrates, inhibitors and inducers. 2022. URL: https://www.fda.gov/drugs/drug-interactions-labeling/drug-development-and-drug-interactions-table-substrates-inhibitors-and-inducers (date of access – 01.01.2023).
- Читкара П., Деннис Г.Д. Глюкокортикоиды – системные и местные. В кн.: Секреты ревматологии. Под. ред. Стерлинга Дж. Уэста (пер. с англ. под ред. О.М. Лесняк). М.: ГЭОТАР-Медиа. 2018; с. 644–651. [Chitkara P., Dennis G.D. Glucocorticoids – systemic and local. In: Rheumatology secrets. Ed. by Sterling J. West (translation from English edited by O.M. Lesnyak). Moscow: GEOTAR-Media. 2018; pp. 644–651 (In Russ.)]. ISBN: 978-5-9704-4508-2.
- Stamp L.K., Chapman P.T. Gout and its comorbidities: Implications for therapy. Rheumatology (Oxford). 2013; 52(1): 34–44. https://dx.doi.org/10.1093/rheumatology/kes211.
- Schumacher H.R. Aspiration and injection therapies for joints. Arthritis Rheum. 2003; 49(3): 413–20. https://dx.doi.org/10.1002/art.11056.
- van Tuyl S.A.C., Slee P.H.T.J. Are the effects of local treatment with glucocorticoids only local? Neth J Med. 2002; 60(3): 130–32.